Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether talactoferrin can improve overall survival
in patients with non-small cell lung cancer (NSCLC) who have been previously treated with two
or more regimens.